 |
|
Genetic study confirms the immune system's role in narcolepsy
May 04, 2009Scientists funded by the National Institutes of Health have identified a gene associated with narcolepsy, a disorder that causes disabling daytime sleepiness, sleep attacks, irresistible bouts of sleep that can strike at any time, and disturbed sleep at night. The gene has a known role in the immune system, which strongly suggests that autoimmunity, in which the immune system turns against the body's own tissues, plays an important role in the disorder.
"The link between narcolepsy and autoimmunity was proposed decades ago, but efforts to verify it have failed repeatedly. Current findings leave little doubt that autoimmunity plays a role," says Merrill Mitler, Ph.D., a program director with the National Institute of Neurological Disorders and Stroke (NINDS). The study was funded principally by NINDS, with additional support from the National Institute of Mental Health (NIMH), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (NIAID), all components of NIH.
The new study, which appears today in Nature Genetics, focused on narcolepsy with cataplexy - a sudden loss of muscle tone that can cause a person to collapse, with or without falling asleep. About 1 in 2,000 Americans have narcolepsy-cataplexy. The symptoms of narcolepsy-cataplexy have been shown to result from the death of a small group of brain cells that normally regulate the sleep-wake cycle by releasing chemicals called hypocretins.
Genetic and environmental factors both clearly play a role in narcolepsy-cataplexy. Until now, the best evidence for autoimmunity as a cause of the disorder was the discovery that nearly everyone with the disorder has unique variants of a gene called HLA-DQB1*0602. This is one of the genes that encodes HLA proteins, which dot the surface of the body's cells and help the immune system identify foreign proteins. Some researchers theorize that the HLA variants found in people with narcolepsy-cataplexy predispose them to an autoimmune reaction that destroys their hypocretin-producing cells.
There are gaps in that theory, however, says Emmanuel Mignot, M.D., Ph.D., director of the Center for Narcolepsy at Stanford University School of Medicine in Palo Alto, Calif., and a Howard Hughes Medical Institute investigator. Dr. Mignot discovered the link between narcolepsy and the hypocretins, and helped establish the link to the HLA system. HLA proteins are found in many tissues including the brain, where they may affect brain development, he says.
HLA variations, however, do not fully account for narcolepsy-cataplexy. Dr. Mignot led a genome-wide association study to search for other genes associated with narcolepsy-cataplexy. These studies involve scanning the genome - the entire set of DNA - for small differences between people who have a disorder and people who do not. Dr. Mignot's study included more than 4,000 individuals, all of whom had the HLA variants that predispose to narcolepsy-cataplexy but only about half of whom had the disorder. Participants were recruited so that many genetic groups were represented. Subjects were from the United States and eight countries in Europe and Asia; hundreds were African-American, Korean, and Japanese, groups known to have a high incidence of the disorder.
The researchers discovered that in addition to unique HLA variants, people with narcolepsy-cataplexy are also more likely to have unique variants of the TCRA gene, which encodes a receptor protein on the surface of T cells. T cells are the mobile infantry of the immune system. In concert with the HLA proteins, the T cell receptor enables T cells to recognize and attack foreign invaders, such as bacteria and viruses. Changes to the T cell receptor could increase the likelihood that the cells will direct their attack against the body.
The findings of Dr. Mignot's group indicate that narcolepsy-cataplexy is linked to autoimmunity and involves T-cells. The research could lead to new approaches to prevention and treatment. One possibility may be preventing the disorder by stopping the effects of the autoimmune process. "If we can define the changes in the T cell receptor associated with narcolepsy-cataplexy, we might be able to develop drugs that block the protein's abnormal activity and prevent the onset of the disorder," says Dr. Mignot. Current treatments such as stimulant drugs for combating daytime sleepiness and antidepressants for cataplexy are only able to control symptoms, and do not address the underlying loss of hypocretin cells.
It is important to note that this study, like most genome-wide association studies, did not identify genetic variants that directly cause narcolepsy-cataplexy. Instead it identifies groups that are more likely to show narcolepsy-cataplexy and groups that are less likely to show the disorder. In people with the HLA variants that predispose to narcolepsy-cataplexy, there is about a 20-fold higher frequency of the disorder if variants in the TCRA gene are present. It is yet to be known which people with the genetic variants will go on to develop narcolepsy-cataplexy.
Other risk factors for narcolepsy-cataplexy remain to be discovered, and Dr. Mignot's findings could provide clues to their identity. For example, further studies to characterize the T cells in people with narcolepsy-cataplexy could help reveal whether specific environmental factors - such as infections - contribute to the disorder. Dr. Mignot's findings also could lead to a better understanding of other autoimmune diseases where HLA genes are known to play a role, such as multiple sclerosis and type 1 diabetes.
NIH/National Institute of Neurological Disorders and Stroke
Genetic and environmental factors both clearly play a role in narcolepsy-cataplexy. Until now, the best evidence for autoimmunity as a cause of the disorder was the discovery that nearly everyone with the disorder has unique variants of a gene called HLA-DQB1*0602. This is one of the genes that encodes HLA proteins, which dot the surface of the body's cells and help the immune system identify foreign proteins. Some researchers theorize that the HLA variants found in people with narcolepsy-cataplexy predispose them to an autoimmune reaction that destroys their hypocretin-producing cells.
There are gaps in that theory, however, says Emmanuel Mignot, M.D., Ph.D., director of the Center for Narcolepsy at Stanford University School of Medicine in Palo Alto, Calif., and a Howard Hughes Medical Institute investigator. Dr. Mignot discovered the link between narcolepsy and the hypocretins, and helped establish the link to the HLA system. HLA proteins are found in many tissues including the brain, where they may affect brain development, he says.
HLA variations, however, do not fully account for narcolepsy-cataplexy. Dr. Mignot led a genome-wide association study to search for other genes associated with narcolepsy-cataplexy. These studies involve scanning the genome - the entire set of DNA - for small differences between people who have a disorder and people who do not. Dr. Mignot's study included more than 4,000 individuals, all of whom had the HLA variants that predispose to narcolepsy-cataplexy but only about half of whom had the disorder. Participants were recruited so that many genetic groups were represented. Subjects were from the United States and eight countries in Europe and Asia; hundreds were African-American, Korean, and Japanese, groups known to have a high incidence of the disorder.
The researchers discovered that in addition to unique HLA variants, people with narcolepsy-cataplexy are also more likely to have unique variants of the TCRA gene, which encodes a receptor protein on the surface of T cells. T cells are the mobile infantry of the immune system. In concert with the HLA proteins, the T cell receptor enables T cells to recognize and attack foreign invaders, such as bacteria and viruses. Changes to the T cell receptor could increase the likelihood that the cells will direct their attack against the body.
The findings of Dr. Mignot's group indicate that narcolepsy-cataplexy is linked to autoimmunity and involves T-cells. The research could lead to new approaches to prevention and treatment. One possibility may be preventing the disorder by stopping the effects of the autoimmune process. "If we can define the changes in the T cell receptor associated with narcolepsy-cataplexy, we might be able to develop drugs that block the protein's abnormal activity and prevent the onset of the disorder," says Dr. Mignot. Current treatments such as stimulant drugs for combating daytime sleepiness and antidepressants for cataplexy are only able to control symptoms, and do not address the underlying loss of hypocretin cells.
It is important to note that this study, like most genome-wide association studies, did not identify genetic variants that directly cause narcolepsy-cataplexy. Instead it identifies groups that are more likely to show narcolepsy-cataplexy and groups that are less likely to show the disorder. In people with the HLA variants that predispose to narcolepsy-cataplexy, there is about a 20-fold higher frequency of the disorder if variants in the TCRA gene are present. It is yet to be known which people with the genetic variants will go on to develop narcolepsy-cataplexy.
Other risk factors for narcolepsy-cataplexy remain to be discovered, and Dr. Mignot's findings could provide clues to their identity. For example, further studies to characterize the T cells in people with narcolepsy-cataplexy could help reveal whether specific environmental factors - such as infections - contribute to the disorder. Dr. Mignot's findings also could lead to a better understanding of other autoimmune diseases where HLA genes are known to play a role, such as multiple sclerosis and type 1 diabetes.
NIH/National Institute of Neurological Disorders and Stroke
Narcolepsy Current Events and Narcolepsy News RSSNarcolepsy is an autoimmune disorder, Stanford researcher says
Ten years ago, Stanford University School of Medicine scientist Emmanuel Mignot, MD, PhD, and his colleagues made headlines when they identified the culprit behind the sleep disorder narcolepsy.
Treating sleep disorders in people with traumatic brain injury may not eliminate symptoms
A study in the April 15 issue of the Journal of Clinical Sleep Medicine is the first to assess the effectiveness of treating sleep disorders in adults with a traumatic brain injury (TBI). Results indicate that treatment may result in the objective resolution of the sleep disorder without improvements in daytime sleepiness or neuropsychological function.
Combating weight gain caused by antipsychotic treatments
Antipsychotic drugs, such as olanzapine (Zyprexa), risperidone (Risperdal) and quetiapine (Seroquel), are commonly used to treat psychotic disorders like schizophrenia, but also bipolar disorder and even behavioral problems related to dementia.
PET imaging focuses on medication's purported ability to improve mental performance
Concerned by the growing numbers of people using stimulant medications such as methylphenidate (MP)-either legally or illegally-to improve attention and focus, researchers used positron emission tomography (PET) imaging with the radiotracer fluorodeoxyglucose (FDG) to assess the effects of the drug on brain function in the normal human brain.
JCSM: A single subjective question can be an effective sleepiness screening tool
A single subjective (SS) question may be an effective screening tool for excessive daytime sleepiness, according to a study published in the April 15 issue of the Journal of Clinical Sleep Medicine (JCSM).
New study in the journal SLEEP finds a high prevalence of eating disorders in narcoleptics
The majority of patients with narcolepsy/cataplexy experience a number of symptoms of eating disorders, with an irresistible craving for food and binge eating as the most prominent features, according to a study published in the March 1 issue of the journal SLEEP.
Journal SLEEP: Methylphenidate can have sleep benefits in adults with ADHD
Treatment with methylphenidate (MPH) appears to have beneficial effects on sleep parameters in adults with ADHD, including increased sleep efficiency and a feeling of improved restorative value of sleep, according to a study published in the March 1 issue of the journal SLEEP.
2 different neural pathways regulate loss and regain of consciousness during general anesthesia
University of Pennsylvania School of Medicine researchers have answered long-running questions about the way that anesthetics act on the body, by showing that the cellular pathway for emerging from anesthesia is different from the one that drugs take to put patients to sleep during operations.
Practice parameters discuss treatment for narcolepsy, other hypersomnias of central origin
Practice parameters published in the December 1 issue of the journal SLEEP serve as both an update of previous practice parameters for the therapy of narcolepsy and as the first practice parameters to address treatment of other hypersomnias of central origin, including idiopathic hypersomnia, recurrent hypersomnia and hypersomnia due to medical condition.
Hormone links sleep, hunger and metabolism, researchers find
While investigating how the hormone orexin might control sleep and hunger, researchers at UT Southwestern Medical Center have discovered, to their surprise, that it activates a protein, HIF-1, long known to stimulate cancerous tumor growth.
More Narcolepsy Current Events and Narcolepsy News Articles
 |
Narcolepsy: A Funny Disorder That's No Laughing Matter by Marguerite J. Utley (Author) This book provides accurate facts about all aspects of narcolepsy, a little-known neurological sleep disorder. It is estimated that 150,000-250,000 people in the U.S. have narcolepsy, but most of those have not yet been diagnosed. In the past, patients have seen an average of five or more physicians over a decade or longer before receiving a correct diagnosis of narcolepsy. As the public becomes better informed and more doctors are entering the field of sleep medicine, people are being diagnosed quicker and at an easlier age. A wealth of information about narcolepsy is available on the internet, but this 166-page book is the most comprehensive, single source of information to be found. In addition to facts, the author relates her personal experiences with all the symptoms... |
 |
Narcolepsy Medical Guide by Qontro Medical Guides (Author) The Narcolepsy Medical Guide is a publication which has been designed to better help readers understand Narcolepsy. This Qontro Medical Guide has been designed with the reader in mind, and is a useful information source for readers at all levels looking to learn more about Narcolepsy. The Narcolepsy Medical Guide is highly recommended for those interested in understanding and learning more about Narcolepsy. |
 |
Psychosocial Aspects of Narcolepsy by Austin Kutscher (Author) This groundbreaking book focuses on the impact narcolepsy has on a person’s day-to-day life. It addresses the diagnosis, treatment, and management of narcolepsy with particular emphasis on psychological and social aspects of care. A multidisciplinary team of nationally and internationally respected scientists, researchers, and clinicians discuss the detrimental effects narcolepsy has on interpersonal relationships, employment, education, recreation, and other aspects of everyday life, from driving an automobile to sexual relations. Narcolepsy’s effects on these and other daily activities are often neglected in the study of the disorder. This book brings into focus the personal and social costs of narcolepsy and discusses the often enormous impact that narcolepsy can have on a... |
 |
Aberrations by Penelope Przekop (Author) Twenty-one-year-old narcoleptic Angel Duet knows her father harbors secrets. He loves and protects her, but his suspicious refusal to discuss her mother s death drives Angel to worship an image created from the little history she does have: her father's sketchy stories and her mother's treasured photography, studies of clouds that have hung in the their foyer for more than twenty years. When her father's girlfriend moves in, the photographs come down, and Angel's search for truth becomes an obsession. As she struggles to uncover the past and gain control over the narcolepsy that often fogs her world, Angel descends into a dizzying realm of drugs, adultery, and confused desire that further obscures reality. As Angel begins to expose a history she could never have imagined, she... |
 |
The Official Patient's Sourcebook on Narcolepsy by James N. Parker (Editor), Philip M. Parker (Editor) This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to narcolepsy (also Gelineau's Syndrome; narcoleptic syndrome; paroxysmal sleep; sleep epilepsy), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on narcolepsy. Given patients'... |
 |
Narcolepsy Narcolepsy is a chronic neurological disorder caused by the brain's inability to regulate the correct times for sleeping and the correct times to be awake. At various moments throughout the day, people with narcolepsy experience sudden urges to sleep. If the urge becomes overwhelming, they may do so for periods lasting from a few seconds to several minutes. The condition is profoundly disabling, interrupting life's basic day to day activities, including working, driving, even conversing with others. Narcolepsy affects about 1 in every 2,000 Americans. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Narcolepsy and Hypersomnia (Lung Biology in Health and Disease) by Claudio Bassetti (Editor), Michel Billiard (Editor), Emmanuel Mignot (Editor) This is the first and only guide to discuss narcolepsy as an autoimmune disease. Compiled by an international group of more than 40 authors, this reference book supplies an engaging and comprehensive review of the major topics and key issues associated with narcolepsy and hypersomnia. Spanning the latest advances in the field, this source covers current diagnostic procedures, genetic developments, explorations of animal models, new definitions and criteria, and improved epidemiological surveys to reflect the explosion of research in this evolving science. |
 |
Narcoleptic Sunday by Jeremy Haun (Author), Brian Koschak (Illustrator) Jack Larch can sleep anywhere. Buses, police stations, strip clubs.... In fact, being a narcoleptic, he can't help but sleep. But Jack's condition doesn't make him a murderer. Or does it? After a one-night stand with the girl of his dreams, he wakes to find her dead and himself a suspect in her murder. Following a series of anonymous clues, Jack fights for his life as he gets closer to the secret surrounding her mysterious death. |
 |
Narcolepsy Ben Folds Five (Primary Contributor) |
 |
Sleep Disorders for Dummies by Max Hirshkowitz (Author), Patricia B. Smith (Author), William C. Dement (Foreword) When the last dinner dishes have been put away and the evening news is over, most of us think about going to bed. But for the millions who suffer from a chronic sleep disorder, going to bed doesn’t necessarily mean going to sleep. And for millions more who experience occasional sleep disturbances, nighttime might not be such a picnic, either. Now there’s an easy-to-follow guide to help you get a good night’s rest. Sleep Disorders For Dummies is for anyone who has trouble sleeping--or has a loved one who suffers from a sleep disorder. Written by a sleep specialist and a medical reporter, this no-nonsense guide helps you: Prevent and manage sleep disorders Improve your sleep habits Find relief from your symptoms Ask your doctor the right questions ... |
| © 2009 BrightSurf.com |